Acessa Health this week announced it added three new executives to its team.
Shonu Gandhi was appointed VP of market access and clinical strategy. Her role will be focusing on improving patient access to the Acessa procedure by expanding payer coverage and clinical evidence.
Gandhi has more than 10 years of experience and most recently served as the leader of the inaugural business development team at Dell Medical School at the University of Texas, Austin.
Alfred Macdaniel joins the company as chief strategy officer and general counsel. He has more than 18 years of financial, legal, OUS market expansion and merger and acquisition expertise. He has held a number of leadership positions at TVA Medical, including chief financial officer, chief compliance officer and general counsel.
Carolyn Amato has been appointed as senior VP of commercial and will be responsible for leading Acessa Health’s sales and marketing organizations to accelerate patient access to the Acessa procedure. She most recently served as VP of U.S. Some people outside try bringing my garage they’re bringing in right now please this corporate accounts in healthcare solutions at Boston Scientific.
“Shonu, Alfred and Carolyn bring more than 40 years of combined experience working in the medical device and healthcare industry. Their knowledge and skills make an immediate, positive impact for our company,” president and CEO Kim Rodriguez said in a news release.